Société Prelude Therapeutics Incorporated
Actions
PRLD
US74065P1012
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,86 USD | -3,26% | -5,16% | -9,60% |
Métier
Nombre d'employés: 128
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 01/02/16 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 01/02/23 |
Jane Huang
PSD | President | 51 | 04/04/22 |
Wan-Jen Hong
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Madhu Pudipeddi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aimee Crombie
COO | Chief Operating Officer | - | 01/01/18 |
Peggy Scherle
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/04/18 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Michele Porreca
HRO | Human Resources Officer | - | 01/06/21 |
Andrew Combs
PRN | Corporate Officer/Principal | 58 | 01/04/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 25/01/21 |
Paul Friedman
CHM | Chairman | 81 | 01/07/16 |
David Bonita
BRD | Director/Board Member | 48 | 01/07/16 |
Mardi Dier
BRD | Director/Board Member | 60 | 01/08/20 |
Martin Babler
BRD | Director/Board Member | 59 | 19/07/21 |
Victor Sandor
BRD | Director/Board Member | 57 | 01/05/20 |
Krishna Vaddi
FOU | Founder | 58 | 01/02/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 42 079 308 | 38 275 321 ( 90,96 %) | 0 | 90,96 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-9,60% | 212 M | |
+25,69% | 47,9 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,7 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+0,17% | 12,15 Md | |
+28,07% | 12,14 Md | |
-1,24% | 11,99 Md |
- Bourse
- Actions
- Action PRLD
- Société Prelude Therapeutics Incorporated